$IDEX
IDEANOMICS, INC. Stock $idex

$idex Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000110465920123041 Filed on November 09, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q4
Revenue	$11.10M	$10.62M	$100.0K
YoY Change	11000.0%	242.14%	-99.34%
Cost Of Revenue	$10.00M	$9.900M	$200.0K
YoY Change	4900.0%	4850.0%	-98.64%
Gross Profit	$1.000M	$714.0K	-$200.0K
YoY Change	-600.0%	-75.03%	-150.0%
Gross Profit Margin	9.01%	6.72%	-200.0%
Selling, General & Admin	$16.70M	$7.636M	$8.300M
YoY Change	101.2%	-1.72%	16.9%
% of Gross Profit	1670.0%	1069.47%
Research & Development	$300.0K	$1.318M	$0.00
YoY Change			-100.0%
% of Gross Profit	30.0%	184.59%
Depreciation & Amortization	$3.660M	$25.17K	$810.0K
YoY Change	351.85%	-96.89%	1925.0%
% of Gross Profit	366.0%	3.53%
Operating Expenses	$20.70M	$12.71M	$9.200M
YoY Change	125.0%	3.66%	24.32%
Operating Profit	-$19.70M	-$12.00M	-$9.400M
YoY Change	109.57%	27.59%	34.29%
Interest Expense	-$18.60M	$2.014M	-$16.80M
YoY Change	10.71%	215.18%	2300.0%
% of Operating Profit
Other Income/Expense, Net	$300.0K	$5.283M	-$300.0K
YoY Change	-200.0%	-5383.0%	-160.0%
Pretax Income	-$58.30M	-$8.723M	-$108.8M
YoY Change	-46.42%	-29.11%	1165.12%
Income Tax	$0.00	$0.00	$900.0K
% Of Pretax Income
Net Earnings	-$51.20M	-$8.286M	-$109.2M
YoY Change	-53.11%	-32.66%	1231.71%
Net Earnings / Revenue	-461.26%	-78.02%	-109200.0%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$184.2K	-$0.03	-$795.9K
COMMON SHARES
Basic Shares Outstanding	239.0M	237.5M shares
Diluted Shares Outstanding		237.5M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$165.8M	$27.60M	$2.600M
YoY Change	6275.54%	1523.53%	-16.13%
Cash & Equivalents	$165.8M	$27.60M	$2.633M
Short-Term Investments	$0.00
Other Short-Term Assets	$3.726M	$581.0K	$600.0K
YoY Change	521.0%	-82.91%	-83.31%
Inventory	$0.00
Prepaid Expenses	$2.629M	$999.0K	$572.0K
Receivables	$7.400M	$4.315M	$2.405M
Other Receivables	$200.0K	$2.100M	$0.00
Total Short-Term Assets	$179.8M	$35.57M	$7.453M
YoY Change	2311.9%	344.56%	-83.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$330.0K	$165.0K	$378.0K
YoY Change	-12.7%	-99.23%	-97.48%
Goodwill	$1.165M	$10.47M	$23.34M
YoY Change	-95.01%		3211.21%
Intangibles	$29.71M	$52.40M	$52.77M
YoY Change	-43.71%		1637.97%
Long-Term Investments	$3.783M	$16.65M	$16.65M
YoY Change	-77.28%	-60.55%	-1.78%
Other Assets	$7.478M	$519.0K	$883.0K
YoY Change	746.89%	-60.08%	-77.84%
Total Long-Term Assets	$54.65M	$102.9M	$119.5M
YoY Change	-54.26%	-34.38%	143.05%
TOTAL ASSETS
Total Short-Term Assets	$179.8M	$35.57M	$7.453M
Total Long-Term Assets	$54.65M	$102.9M	$119.5M
Total Assets	$234.4M	$138.5M	$126.9M
YoY Change	84.66%	-15.98%	34.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.057M	$4.738M	$3.380M
YoY Change	49.62%	215.87%	-82.46%
Accrued Expenses	$2.200M	$1.400M	$2.000M
YoY Change	10.0%	55.56%	150.0%
Deferred Revenue	$1.129M
YoY Change
Short-Term Debt	$600.0K	$3.800M	$3.000M
YoY Change	-80.0%
Long-Term Debt Due	$0.00	$9.000M	$5.000M
YoY Change	-100.0%	592.31%	25.0%
Total Short-Term Liabilities	$13.06M	$29.74M	$36.76M
YoY Change	-64.46%	87.01%	22.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$6.600M
YoY Change	-100.0%	-100.0%	-41.59%
Other Long-Term Liabilities	$7.275M	$514.0K	$0.00
YoY Change		-95.95%
Total Long-Term Liabilities	$7.275M	$514.0K	$0.00
YoY Change		-98.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.06M	$29.74M	$36.76M
Total Long-Term Liabilities	$7.275M	$514.0K	$0.00
Total Liabilities	$32.64M	$49.33M	$66.95M
YoY Change	-51.24%	3.42%	34.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$346.9M	-$295.7M	-$248.5M
YoY Change	39.6%		65.68%
Common Stock	$345.0K	$239.0K	$150.0K
YoY Change	130.0%		45.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$186.6M	$67.18M	$33.56M
YoY Change
Total Liabilities & Shareholders Equity	$234.4M	$138.5M	$126.9M
YoY Change	84.66%	-15.98%	34.71%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q4
OPERATING ACTIVITIES
Net Income	-$51.20M	-$8.286M	-$109.2M
YoY Change	-53.11%	-32.66%	1231.71%
Depreciation, Depletion And Amortization	$3.660M	$25.17K	$810.0K
YoY Change	351.85%	-96.89%	1925.0%
Cash From Operating Activities	-$19.55M	-$11.53M	-$5.070M
YoY Change	285.6%	308.87%	101.19%
INVESTING ACTIVITIES
Capital Expenditures	-$140.0K	-$10.00K	-$10.00K
YoY Change	1300.0%	-97.67%	-99.85%
Acquisitions
YoY Change
Other Investing Activities	-$2.870M	$1.400M	-$50.00K
YoY Change	5640.0%	48.94%	-99.31%
Cash From Investing Activities	-$3.010M	$1.390M	-$50.00K
YoY Change	5920.0%	172.55%	-99.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	162.3M	0.000	6.040M
YoY Change	2587.25%	-100.0%	62.8%
NET CHANGE
Cash From Operating Activities	-19.55M	-11.53M	-5.070M
Cash From Investing Activities	-3.010M	1.390M	-50.00K
Cash From Financing Activities	162.3M	0.000	6.040M
Net Change In Cash	139.8M	-10.14M	920.0K
YoY Change	15090.22%	-1613.43%	-107.13%
FREE CASH FLOW
Cash From Operating Activities	-$19.55M	-$11.53M	-$5.070M
Capital Expenditures	-$140.0K	-$10.00K	-$10.00K
Free Cash Flow	-$19.41M	-$11.52M	-$5.060M
YoY Change	283.6%	382.01%	-215.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Entity Central Index Key EntityCentralIndexKey	0000837852
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7000000
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7000000
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	238871366
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	149692953
	dei	Document Type DocumentType	10-Q
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2020Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	586000
CY2019Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2284000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52771000
CY2020Q3	us-gaap	Goodwill Goodwill	10472000
CY2019Q4	us-gaap	Goodwill Goodwill	23344000
CY2020Q3	us-gaap	Long Term Investments LongTermInvestments	22651000
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	22621000
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1778374
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4315000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7357000
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1441 Broadway, 5th Floor, Suite 5116
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6934000
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
	dei	City Area Code CityAreaCode	212
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2405000
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	519000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	883000
	dei	Local Phone Number LocalPhoneNumber	206-1216
CY2020Q3	us-gaap	Assets Assets	138464000
CY2019Q4	us-gaap	Assets Assets	126945000
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4738000
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3380000
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
CY2020Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1178000
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	477000
CY2020Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	906000
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	999000
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35561
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	923000
CY2020Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1333000
	dei	Trading Symbol TradingSymbol	IDEX
CY2020Q3	idex	Fintech Village Non Core Asset Noncurrent FintechVillageNonCoreAssetNoncurrent	9337000
CY2019Q4	idex	Fintech Village Non Core Asset Noncurrent FintechVillageNonCoreAssetNoncurrent	12561000
	dei	Entity Registrant Name EntityRegistrantName	IDEANOMICS, INC.
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52398000
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	238971366
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27605000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2633000
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	572000
CY2020Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1601000
CY2019Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1256000
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	464000
CY2019Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	581000
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	587000
CY2020Q3	us-gaap	Assets Current AssetsCurrent	35565000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	7453000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	165000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	378000
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	3962000
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4195000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6466000
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	520000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1113000
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4082000
CY2019Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	5094000
CY2020Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-664000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	12421000
CY2020Q3	idex	Promissory Notes Current PromissoryNotesCurrent	3750000
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	290000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58737000
CY2019Q4	idex	Promissory Notes Current PromissoryNotesCurrent	3000000
CY2020Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9033000
CY2019Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1753000
CY2020Q3	idex	Convertible Promissory Notes Payable Related Parties Current ConvertiblePromissoryNotesPayableRelatedPartiesCurrent	0
CY2019Q4	idex	Convertible Promissory Notes Payable Related Parties Current ConvertiblePromissoryNotesPayableRelatedPartiesCurrent	3260000
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	29735000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36755000
CY2020Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	4653000
CY2019Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5089000
CY2020Q3	idex	Convertible Promissory Notes Payable Related Parties Noncurrent ConvertiblePromissoryNotesPayableRelatedPartiesNoncurrent	0
CY2019Q4	idex	Convertible Promissory Notes Payable Related Parties Noncurrent ConvertiblePromissoryNotesPayableRelatedPartiesNoncurrent	1551000
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	514000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6820000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6222000
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7608000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	12235000
CY2020Q3	us-gaap	Liabilities Liabilities	49330000
CY2019Q4	us-gaap	Liabilities Liabilities	66946000
CY2020Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	7000000
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	7000000
CY2020Q3	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	3500000
CY2019Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	3500000
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1262000
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1262000
CY2020Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	7370000
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	238871366
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	149692953
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	239000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	150000
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	362346000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	282554000
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-295693000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-248481000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	67182000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	33559000
CY2020Q3	us-gaap	Minority Interest MinorityInterest	13320000
CY2019Q4	us-gaap	Minority Interest MinorityInterest	25178000
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	80502000
CY2019Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2854000
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	9000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10363000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2299000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1374000
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4179000
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	138464000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126945000
CY2020Q3	idex	Revenue From Third Parties RevenueFromThirdParties	10618000
CY2019Q3	idex	Revenue From Third Parties RevenueFromThirdParties	250000
	idex	Revenue From Third Parties RevenueFromThirdParties	15681000
	idex	Revenue From Third Parties RevenueFromThirdParties	950000
CY2020Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2000
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	43554000
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10620000
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3104000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15690000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44504000
CY2020Q3	idex	Third Parties Costs ThirdPartiesCosts	9906000
CY2019Q3	idex	Third Parties Costs ThirdPartiesCosts	244000
	idex	Third Parties Costs ThirdPartiesCosts	14674000
	idex	Third Parties Costs ThirdPartiesCosts	751000
CY2020Q3	us-gaap	Related Party Costs RelatedPartyCosts	0
CY2019Q3	us-gaap	Related Party Costs RelatedPartyCosts	0
	us-gaap	Related Party Costs RelatedPartyCosts	2000
	us-gaap	Related Party Costs RelatedPartyCosts	467000
CY2020Q3	us-gaap	Gross Profit GrossProfit	714000
CY2019Q3	us-gaap	Gross Profit GrossProfit	2860000
	us-gaap	Gross Profit GrossProfit	1014000
	us-gaap	Gross Profit GrossProfit	43286000
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7636000
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7770000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20188000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18443000
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1318000
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1318000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	3968000
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	1389000
	us-gaap	Professional Fees ProfessionalFees	8096000
	us-gaap	Professional Fees ProfessionalFees	3918000
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3275000
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2299000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2900000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	695000
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	806000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1651000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1420000
	us-gaap	Operating Income Loss OperatingIncomeLoss	17206000
	us-gaap	Profit Loss ProfitLoss	12881000
CY2020Q3	idex	Deemed Dividend Related To Warrant Repricing DeemedDividendRelatedToWarrantRepricing	0
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	12713000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	12264000
	us-gaap	Operating Expenses OperatingExpenses	38716000
	us-gaap	Operating Expenses OperatingExpenses	26080000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11999000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9404000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37702000
CY2020Q3	us-gaap	Interest Expense InterestExpense	2014000
CY2019Q3	us-gaap	Interest Expense InterestExpense	639000
	us-gaap	Interest Expense InterestExpense	14061000
	us-gaap	Interest Expense InterestExpense	1955000
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7000
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-40000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-606000
CY2020Q3	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0
CY2019Q3	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	1057000
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	1057000
CY2020Q3	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss	0
CY2019Q3	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss	3179000
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss	0
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss	3179000
CY2020Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0
CY2019Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	2266000
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5283000
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6272000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-156000
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8723000
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12305000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-47765000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12367000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-514000
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-12305000
	us-gaap	Profit Loss ProfitLoss	-47765000
CY2019Q3	idex	Deemed Dividend Related To Warrant Repricing DeemedDividendRelatedToWarrantRepricing	0
	idex	Deemed Dividend Related To Warrant Repricing DeemedDividendRelatedToWarrantRepricing	184000
	idex	Deemed Dividend Related To Warrant Repricing DeemedDividendRelatedToWarrantRepricing	0
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-437000
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1408000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-737000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8286000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13713000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47212000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11507000
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237535999
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127609748
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	191976856
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113964933
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237535999
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127609748
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	191976856
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118319893
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-12305000
	us-gaap	Profit Loss ProfitLoss	-47765000
	us-gaap	Profit Loss ProfitLoss	12881000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2019Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1356000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1639000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	103000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7367000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-12281000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46126000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12984000
	idex	Deemed Dividend Related To Warrant Repricing DeemedDividendRelatedToWarrantRepricing	184000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	122000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1470000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-51000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1420000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7245000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13751000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-46361000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11564000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43212000
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	224000
CY2019Q1	idex	Stock Issued During Period Value Assets Of Solid Opinion Inc StockIssuedDuringPeriodValueAssetsOfSolidOpinionInc	7155000
CY2019Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2050000
CY2019Q1	us-gaap	Profit Loss ProfitLoss	19909000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	147000
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	72697000
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3703000
CY2019Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	5350000
CY2019Q2	us-gaap	Profit Loss ProfitLoss	5277000
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-68000
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	86959000
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2547000
CY2019Q3	idex	Stock Issued During Period Value Acquisitions Of Blackhorse Ventures StockIssuedDuringPeriodValueAcquisitionsOfBlackhorseVentures	1500000
CY2019Q3	idex	Stock Issued During Period Value Acquisitions Of Glory Connection StockIssuedDuringPeriodValueAcquisitionsOfGloryConnection	24380000
CY2019Q3	idex	Stock Issued During Period Value Acquisitions Of Dbot StockIssuedDuringPeriodValueAcquisitionsOfDbot	9819000
CY2019Q3	idex	Stock Issued During Period Value Release From Collateral StockIssuedDuringPeriodValueReleaseFromCollateral	372000
CY2019Q3	idex	Stock Issued During Period Value For Releasing Grapevine As Collateral Convertible Note StockIssuedDuringPeriodValueForReleasingGrapevineAsCollateralConvertibleNote	2500000
CY2019Q3	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	446000
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-12305000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24000
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	116242000
CY2018	idex	Stock Issued During Period Value Conversion Of Convertible Securities Two StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo	1100000
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1100000
CY2019Q2	idex	Stock Issued For Investment From Minority Stockholders StockIssuedForInvestmentFromMinorityStockholders	575431
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58737000
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2202000
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	240000
CY2020Q1	idex	Stock Issued During Period Value Issued For Interest Id Venturs StockIssuedDuringPeriodValueIssuedForInterestIdVenturs	21000
CY2020Q1	idex	Stock Issued During Period Value Acquisitions Of Dbot StockIssuedDuringPeriodValueAcquisitionsOfDbot	6748000
CY2020Q1	idex	Stock Issued During Period Value Issued For Warrants Exercised StockIssuedDuringPeriodValueIssuedForWarrantsExercised	1000000
CY2020Q1	idex	Stock Issued During Period Value Acquisitions Of Ya Ii StockIssuedDuringPeriodValueAcquisitionsOfYaIi	593000
CY2020Q1	idex	Noncontrolling Interest Increase From Tree Technologies Ppa Adjustment NoncontrollingInterestIncreaseFromTreeTechnologiesPpaAdjustment	-11454000
CY2020Q1	idex	Noncontrolling Interest Increase From Contribution Dbot NoncontrollingInterestIncreaseFromContributionDbot	100000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12726000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7000
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	45468000
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3394000
CY2020Q2	idex	Stock Issued During Period Value Acquisitions Of Dbot StockIssuedDuringPeriodValueAcquisitionsOfDbot	293000
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3000000
CY2020Q2	idex	Stock Issued During Period Value Conversion Of Convertible Notes Two StockIssuedDuringPeriodValueConversionOfConvertibleNotesTwo	1568000
CY2020Q2	idex	Stock Issued During Period Value Issuance Of Debt One StockIssuedDuringPeriodValueIssuanceOfDebtOne	1518000
CY2020Q2	idex	Stock Issued During Period Value Issuance Of Debt Two StockIssuedDuringPeriodValueIssuanceOfDebtTwo	797000
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	309000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	2265000
CY2020Q2	idex	Stock Issued During Period Value Issued For Warrants Exercised StockIssuedDuringPeriodValueIssuedForWarrantsExercised	2500000
CY2020Q2	idex	Stock Issued During Period Value Acquisitions Of Ya Ii StockIssuedDuringPeriodValueAcquisitionsOfYaIi	5083000
CY2020Q2	idex	Stock Issued During Period Value Acquisitions Of Id Venturas StockIssuedDuringPeriodValueAcquisitionsOfIdVenturas	4617000
CY2020Q2	idex	Stock Issued During Period Value Issuance For Financing StockIssuedDuringPeriodValueIssuanceForFinancing	32500000
CY2020Q2	idex	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments Two AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustmentsTwo	2661000
CY2020Q2	idex	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments Three AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustmentsThree	817000
CY2020Q2	idex	Stock Issued During Period Value Issued For Warrants Exercised Id Ventura StockIssuedDuringPeriodValueIssuedForWarrantsExercisedIdVentura	3127000
CY2020Q2	idex	Noncontrolling Interest Increase From Tree Technologies Ppa Adjustment NoncontrollingInterestIncreaseFromTreeTechnologiesPpaAdjustment	-131000
CY2020Q2	idex	Profit Loss Excluding Dividend For Redeemable Non Controlling Interest And Warrants ProfitLossExcludingDividendForRedeemableNonControllingInterestAndWarrants	-26711000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	276000
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83351000
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3252000
CY2020Q3	idex	Stock Issued During Period Value Acquisitions Of Dbot StockIssuedDuringPeriodValueAcquisitionsOfDbot	1033000
CY2020Q3	idex	Stock Issued During Period Value Common Stock And Warrants Issuance For Professional Fee StockIssuedDuringPeriodValueCommonStockAndWarrantsIssuanceForProfessionalFee	343000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1356000
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	80502000
	us-gaap	Profit Loss ProfitLoss	-47765000
	us-gaap	Profit Loss ProfitLoss	12881000
	us-gaap	Share Based Compensation ShareBasedCompensation	8848000
	us-gaap	Share Based Compensation ShareBasedCompensation	6474000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1651000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1420000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	585000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0
	idex	Non Cash Interest Expense NonCashInterestExpense	14143000
	idex	Non Cash Interest Expense NonCashInterestExpense	2266000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-606000
	idex	Digital Tokens Received As Payment For Services DigitalTokensReceivedAsPaymentForServices	0
	idex	Digital Tokens Received As Payment For Services DigitalTokensReceivedAsPaymentForServices	40700000
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	1057000
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss	0
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss	3179000
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	2266000
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0
	idex	Asset Impairment Charge AssetImpairmentCharge	4143000
	idex	Asset Impairment Charge AssetImpairmentCharge	2299000
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	6220000
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0
	idex	Settlement Of Operating Lease Liabilities SettlementOfOperatingLeaseLiabilities	5706000
	idex	Settlement Of Operating Lease Liabilities SettlementOfOperatingLeaseLiabilities	0
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2900000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2496000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2814000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	689000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2447000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1358000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1024000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	701000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	150000
	idex	Increase Or Decrease In Amount Due To Related Parties IncreaseOrDecreaseInAmountDueToRelatedParties	1542000
	idex	Increase Or Decrease In Amount Due To Related Parties IncreaseOrDecreaseInAmountDueToRelatedParties	-104000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3827000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3217000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21918000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8712000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1809000
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1469000
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	0
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	694000
	idex	Payments To Acquire Interest In Subsidiaries PaymentsToAcquireInterestInSubsidiaries	0
	idex	Payments To Acquire Interest In Subsidiaries PaymentsToAcquireInterestInSubsidiaries	-247000
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	870000
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1910000
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-486000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1738000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2000000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4802000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	39128000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2500000
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7148000
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0
	idex	Borrowings From Small Business Association Paycheck Protection Program BorrowingsFromSmallBusinessAssociationPaycheckProtectionProgram	460000
	idex	Borrowings From Small Business Association Paycheck Protection Program BorrowingsFromSmallBusinessAssociationPaycheckProtectionProgram	0
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2999000
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1765000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45737000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9067000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	1639000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-37000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	24972000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1420000
CY2019Q4	us-gaap	Cash Cash	2633000
CY2018Q4	us-gaap	Cash Cash	3106000
CY2020Q3	us-gaap	Cash Cash	27605000
CY2019Q3	us-gaap	Cash Cash	1686000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
	us-gaap	Interest Paid Net InterestPaidNet	311000
	us-gaap	Interest Paid Net InterestPaidNet	0
	us-gaap	Stock Issued1 StockIssued1	8074000
	us-gaap	Stock Issued1 StockIssued1	0
	idex	Stock Issued During Period Value Acquisitions Of Convertible Note Conversion StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion	20069000
	idex	Stock Issued During Period Value Acquisitions Of Convertible Note Conversion StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion	0
	idex	Purchase Price Adjustment In Acquisitions PurchasePriceAdjustmentInAcquisitions	12848000
	idex	Purchase Price Adjustment In Acquisitions PurchasePriceAdjustmentInAcquisitions	0
	idex	Disposal Assets In Exchange For Gtb DisposalAssetsInExchangeForGtb	0
	idex	Disposal Assets In Exchange For Gtb DisposalAssetsInExchangeForGtb	20219000
	idex	Stock Issued During Period Value Acquisition Of Intangible Assets StockIssuedDuringPeriodValueAcquisitionOfIntangibleAssets	0
	idex	Stock Issued During Period Value Acquisition Of Intangible Assets StockIssuedDuringPeriodValueAcquisitionOfIntangibleAssets	10005000
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27600000
	idex	Effects Of Covid19 Policy Textblock EffectsOfCovid19PolicyTextblock	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Effects of COVID-19</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Novel Coronavirus 2019 (“COVID-19”) is an infectious disease cause by severe acute respiratory syndrome coronavirus. The disease was first identified in December 2019 in Wuhan, the capital of China’s Hubei province, and has since spread globally, resulting in the ongoing COVID-19 pandemic. As of October 31, 2020, over 44.7 million cases had been reported across the globe, resulting in 1.2 million deaths.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The spread of COVID-19 has caused significant disruption to society as a whole, including the workplace. The resulting impact to the global supply chain has disrupted most aspects of national and international commerce, with government-mandated social distancing measures imposing stay-at-home and work-from-home orders in almost every country. The effects of social distancing has shut down significant parts of the local, regional, national, and international economies with the exception of government designated essential services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In many parts of the world, stay-at-home and work-from-home orders were relaxed during the summer of 2020 as the effects of the Coronavirus appeared to lessen, and economic activity began to recover. However, commencing in the autumn and fall of 2020, the U.S. as well as countries in Europe began to experience an increase in new COVID-19 cases, and in some cases local, state, and national governments began to reinstate restrictive measures to stem the spread of the virus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Public health experts have expressed concern that the influenza season in the northern hemisphere will coincide with a spread of COVID-19 cases, adding further stress to the affected populations, businesses, governments, and economies. The future effects of the virus are difficult to predict, due to uncertainty about the course of the virus, and the prospects for a vaccine as well as its global implementation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company assesses the recoverability of goodwill and other indefinite-lived intangible assets in the fourth quarter of each year, or more frequently if circumstances warrant. The Company assesses the recoverability of other long-lived assets as circumstances warrant, and in the nine months ended September 30, 2020 did not consider any long-lived assets to be impaired other than certain right of use and fixed assets, including assets comprising a portion of Fintech Village. Many of the Company’s operations are in the development or early stage, have not had significant revenues to date, and the Company does not anticipate significant adverse effects on its operations’ revenue as compared to its business plan in the near- or mid-term, although the future effects of COVID-19 may result in regional restrictive measures which may constrain the Company’s operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company continues to monitor the overall situation with COVID-19 and its effects on both local, regional and global economies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Resulting Delay in Documentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In the three months ended March 31, 2020, the Company commenced the process of formulating and implementing a share-based compensation plan whereby key employees and certain consultants of its MEG business unit and wholly-owned subsidiary would benefit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As one component of this process, the Company had initially transferred 10,000 common shares of MEG, representing 20.0% of the overall outstanding common shares, to Merry Heart Technology Limited ("MHTL"),who was intended to act as a trustee over these shares, for a nominal amount. It was the Company’s intent that this arrangement would be structured in a manner similar to other trusts used to effect share-based compensation plans, and would qualify as a VIE and consequently be consolidated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">However, the disruption caused by the COVID-19 virus, particularly in China, where many of the Company’s personnel and business advisors are located, initially delayed the Company’s efforts to implement this share-based compensation plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company has determined not to proceed with the MEG share-based compensation plan described above, and the parties have declared the transfer of the MEG shares, which was not believed to be substantive, to be null and void and they have reverted to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">No share-based awards had been granted to employees or consultants pursuant to this arrangement as originally contemplated.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On an ongoing basis, management evaluates the Company's estimates, including those related to the bad debt allowance, variable consideration, fair values of financial instruments, intangible assets (including digital currencies) and goodwill, useful lives of intangible assets and property and equipment, asset retirement obligations, income taxes, and contingent liabilities, among others. The Company bases its estimates on assumptions, both historical and forward looking, that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company has renamed captions in its condensed consolidated balance sheet, condensed consolidated statement of operations, and its condensed consolidated statement of cash flows. There were no changes to the composition of these accounts, and therefore no change to the condensed consolidated financial accounts aside from the renaming of the captions. </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:30.81%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Statement</b></p></td><td style="vertical-align:bottom;width:2.32%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;width:2.36%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;width:26.4%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous caption</b></p></td><td style="vertical-align:bottom;width:2.34%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;width:2.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;width:33.41%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Current caption</b></p></td></tr><tr><td style="vertical-align:top;width:30.81%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Condensed consolidated balance sheet</p></td><td style="vertical-align:top;width:2.32%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:2.36%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:26.4%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Acquisition earn-out liability</p></td><td style="vertical-align:top;width:2.34%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:2.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:33.41%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration</p></td></tr><tr><td style="vertical-align:top;width:30.81%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Condensed consolidated statement of operations</p></td><td style="vertical-align:top;width:2.32%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:2.36%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:26.4%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Acquisition earn-out/true up expense, net</p></td><td style="vertical-align:top;width:2.34%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:2.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:33.41%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of contingent consideration, net</p></td></tr><tr><td style="vertical-align:top;width:30.81%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Condensed consolidated statement of cash flows</p></td><td style="vertical-align:top;width:2.32%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:2.36%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:26.4%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Acquisition earn-out expense</p></td><td style="vertical-align:top;width:2.34%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:2.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:top;width:33.41%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of contingent consideration, net</p></td></tr></table>
	idex	Proceeds From Issuance Or Sale Of Equity And Debt ProceedsFromIssuanceOrSaleOfEquityAndDebt	48200000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	39100000
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7100000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2000000.0
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	4600000
	idex	Due To Related Parties Converted To Common Stock DueToRelatedPartiesConvertedToCommonStock	1500000
	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	13900000
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	700000
CY2019Q2	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	600000
CY2019Q2	idex	Non Controlling Interest Carrying Amount NonControllingInterestCarryingAmount	500000
CY2019Q2	idex	Business Acquisition Change In Additional Paid In Capital BusinessAcquisitionChangeInAdditionalPaidInCapital	1100000
CY2020Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4900000
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2405000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	585000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4315000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2405000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	600000
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	22639000
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	606000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	746000
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	441000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	368000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	165000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	378000
CY2020Q3	idex	Impairment Loss ImpairmentLoss	200000
CY2019Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	5094000
	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	0
	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	441000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	0
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	0
CY2020Q3	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4653000
	idex	Capitalized Cost Related To The Legal And Architect Costs CapitalizedCostRelatedToTheLegalAndArchitectCosts	0
CY2019	idex	Capitalized Cost Related To The Legal And Architect Costs CapitalizedCostRelatedToTheLegalAndArchitectCosts	2700000
CY2020Q3	idex	Impairment Loss For Capitalized Architect Costs ImpairmentLossForCapitalizedArchitectCosts	2700000
CY2020Q3	idex	Impairment Loss For Remaining Building ImpairmentLossForRemainingBuilding	300000
CY2020Q3	idex	Asset Retirement Cost Associated With Remaining Building AssetRetirementCostAssociatedWithRemainingBuilding	200000
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	115000
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	448000
CY2018Q4	us-gaap	Goodwill Goodwill	705000
CY2019Q4	us-gaap	Goodwill Goodwill	23344000
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-12848000
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-24000
CY2020Q3	us-gaap	Goodwill Goodwill	10472000
CY2020Q3	idex	Indefinite Lived Intangible Assets Excluding Good Will Gross IndefiniteLivedIntangibleAssetsExcludingGoodWillGross	56174000
CY2020Q3	idex	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	-3829000
CY2020Q3	idex	Indefinite Lived Intangible Assets Accumulated Impairment Loss IndefiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	0
CY2020Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	52345000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	54993000
CY2019Q4	idex	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	-2275000
CY2019Q4	idex	Indefinite Lived Intangible Assets Accumulated Impairment Loss IndefiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	0
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	52718000
CY2020Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	56227000
CY2020Q3	idex	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	3829000
CY2020Q3	idex	Impairment Loss Of Intangible Assets ImpairmentLossOfIntangibleAssets	0
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52398000
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	55046000
CY2019Q4	idex	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2275000
CY2019Q4	idex	Impairment Loss Of Intangible Assets ImpairmentLossOfIntangibleAssets	0
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52771000
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1600000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	668000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2615000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2494000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2485000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1709000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	42374000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52345000
CY2020Q3	idex	Non Marketable Equity Investment NonMarketableEquityInvestment	6005000
CY2019Q4	idex	Non Marketable Equity Investment NonMarketableEquityInvestment	5967000
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	16646000
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	16654000
CY2020Q3	us-gaap	Long Term Investments LongTermInvestments	22651000
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	22621000
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2019Q3	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2020Q3	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2019Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	3200000
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	16654000
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-8000
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
	idex	Equity Method Investment Foreign Currency Transaction And Translation Adjustment EquityMethodInvestmentForeignCurrencyTransactionAndTranslationAdjustment	0
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	16646000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7400000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7300000
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y9M18D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.044
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6900000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7300000
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	519000
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	391000
	us-gaap	Operating Lease Cost OperatingLeaseCost	1488000
	us-gaap	Operating Lease Cost OperatingLeaseCost	1264000
CY2020Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82000
CY2019Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	78000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	279000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	251000
CY2020Q3	us-gaap	Sublease Income SubleaseIncome	11000
CY2019Q3	us-gaap	Sublease Income SubleaseIncome	11000
	us-gaap	Sublease Income SubleaseIncome	74000
	us-gaap	Sublease Income SubleaseIncome	11000
CY2020Q3	us-gaap	Lease Cost LeaseCost	590000
CY2019Q3	us-gaap	Lease Cost LeaseCost	458000
CY2019Q4	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	500000
	us-gaap	Lease Cost LeaseCost	1693000
	us-gaap	Lease Cost LeaseCost	1504000
CY2019Q4	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	100000
	us-gaap	Operating Lease Payments OperatingLeasePayments	961000
	us-gaap	Operating Lease Payments OperatingLeasePayments	968000
CY2019Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	935000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	935000
CY2019Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2900000
CY2019Q4	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	100000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	260000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	721000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	614000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	632000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	645000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7009000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9881000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2541000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7340000
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	15595000
CY2020Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12783000
CY2019Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	26932000
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	14653000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3030000
CY2020Q3	idex	Long Term Debt Maturities Repayments Of Interest In Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfInterestInRemainderOfFiscalYear	180000
CY2020Q3	idex	Long Term Debt Maturitie Of Interest Expense In Remainder Of Fiscal Year LongTermDebtMaturitieOfInterestExpenseInRemainderOfFiscalYear	1997000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12105000
CY2020Q3	idex	Long Term Debt Maturities Repayments Of Interest In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths	2875000
CY2020Q3	idex	Long Term Debt Maturities Of Interest Expense In Next Twelve Months LongTermDebtMaturitiesOfInterestExpenseInNextTwelveMonths	3878000
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	15135000
CY2020Q3	idex	Long Term Debt Maturities Repayments Of Interest Due LongTermDebtMaturitiesRepaymentsOfInterestDue	3055000
CY2020Q3	idex	Long Term Debt Maturities Interest Expense Due LongTermDebtMaturitiesInterestExpenseDue	5875000
CY2019Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.84
CY2019Q4	idex	Debt Instrument Convertible Conversion Price Adjusted DebtInstrumentConvertibleConversionPriceAdjusted	1.00
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.5869
CY2019Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.84
CY2019Q4	idex	Debt Instrument Convertible Conversion Price Adjusted DebtInstrumentConvertibleConversionPriceAdjusted	1.00
CY2019Q4	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	200000
CY2019Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2700000
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.65
CY2019Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2000000.0
CY2019Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1000000.0
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8286000
CY2019Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.00
CY2019Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.100
CY2019Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	400000
CY2019Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2200000
CY2019Q4	idex	Intrinsic Value Of Beneficial Conversion Feature Convertible Notes IntrinsicValueOfBeneficialConversionFeatureConvertibleNotes	500000
CY2019Q4	idex	Intrinsic Value Of Beneficial Conversion Feature Convertible Notes IntrinsicValueOfBeneficialConversionFeatureConvertibleNotes	500000
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	2000000.0
CY2019Q4	us-gaap	Warrants And Rights Outstanding Measurement Input WarrantsAndRightsOutstandingMeasurementInput	1.54
CY2019Q4	idex	Percentage Of Discount Issued On Convertible Loans PercentageOfDiscountIssuedOnConvertibleLoans	0.150
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	idex	Common Shares In Escrow Account CommonSharesInEscrowAccount	25500000
CY2019Q4	us-gaap	Impairment Of Investments ImpairmentOfInvestments	61100000
CY2019Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	800000
CY2019Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	600000
CY2019Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	200000
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1700000
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3300000
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2500000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8800000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6500000
CY2020Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7300000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	8800000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6000000.0
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
	idex	Weighted Average Remaining Life Of Warrants WeightedAverageRemainingLifeOfWarrants	P4Y3M18D
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1650000
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8995906
CY2019Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113964933
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13713000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47212000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11507000
CY2020Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127609748
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	191976856
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	400000
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	125000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8286000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13713000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-47212000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11632000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	237535999
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	933333
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	22823
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2777687
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	621117
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237535999
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127609748
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	191976856
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118319893
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	68789000
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34354000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	67454000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30323000
	idex	Valuation Allowance Percentage ValuationAllowancePercentage	1
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-500000
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	400000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0443
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	1700000
CY2020Q3	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	1300000
CY2020Q3	idex	Cash On Hand And Demand Deposists At Banks CashOnHandAndDemandDeposistsAtBanks	200000

Files In Submission

Name	View Source	Status
0001104659-20-123041-index-headers.html	Edgar Link	pending
0001104659-20-123041-index.html	Edgar Link	pending
0001104659-20-123041.txt	Edgar Link	pending
0001104659-20-123041-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
idex-20200930.xsd	Edgar Link	pending
idex-20200930x10q.htm	Edgar Link	pending
idex-20200930x10q_htm.xml	Edgar Link	completed
idex-20200930xex31d1.htm	Edgar Link	pending
idex-20200930xex31d2.htm	Edgar Link	pending
idex-20200930xex32d1.htm	Edgar Link	pending
idex-20200930xex32d2.htm	Edgar Link	pending
idex-20200930_cal.xml	Edgar Link	unprocessable
idex-20200930_def.xml	Edgar Link	unprocessable
idex-20200930_lab.xml	Edgar Link	unprocessable
idex-20200930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IDEX
IDEANOMICS, INC. Stock $idex

2020 Q4 Form 10-Q Financial Statement

#000110465920123041 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDEX IDEANOMICS, INC. Stock $idex

2020 Q4 Form 10-Q Financial Statement

#000110465920123041 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDEX
IDEANOMICS, INC. Stock $idex